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Catecholamine Stress Alters Neutrophil Trafficking
and Impairs Wound Healing by b2-Adrenergic
Receptor–Mediated Upregulation of IL-6
Min-Ho Kim1,2, Farzam Gorouhi3, Sandra Ramirez3, Jennifer L. Granick4, Barbara A. Byrne4,
Athena M. Soulika3,5, Scott I. Simon1 and R. Rivkah Isseroff3,6
Stress-induced hormones can alter the inflammatory response to tissue injury; however, the precise mechanism
by which epinephrine influences inflammatory response and wound healing is not well defined. Here
we demonstrate that epinephrine alters the neutrophil (polymorphonuclear leukocyte (PMN))-dependent
inflammatory response to a cutaneous wound. Using noninvasive real-time imaging of genetically tagged PMNs
in a murine skin wound, chronic, epinephrine-mediated stress was modeled by sustained delivery of
epinephrine. Prolonged systemic exposure of epinephrine resulted in persistent PMN trafficking to the wound
site via an IL-6-mediated mechanism, and this in turn impaired wound repair. Further, we demonstrate that
b2-adrenergic receptor–dependent activation of proinflammatory macrophages is critical for epinephrine-
mediated IL-6 production. This study expands our current understanding of stress hormone–mediated
impairment of wound healing and provides an important mechanistic link to explain how epinephrine stress
exacerbates inflammation via increased number and lifetime of PMNs.
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INTRODUCTION
Impairment of skin wound healing results in chronic skin
ulceration, a burgeoning clinical problem. Common etiologies
include venous leg ulcers, diabetic foot ulcers, and pressure
ulcers. Although there are diverse pathologic processes at
work in these different entities, one common effector pathway
is believed to be persistent wound inflammation (Diegelmann
and Evans, 2004; Liu et al., 2011), which is associated with
prolongation of healing in venous, diabetic, and pressure
ulcers (Gohel et al., 2008; Pradhan et al., 2009).
One recognized modulator of the inflammatory response is
stress, either acute or chronic (Viswanathan et al., 2005;
Gouin et al., 2008). Various types of stressors can activate
either the hypothalamic–pituitary–adrenal axis or the sympa-
thetic nerve system, resulting in the systemic release of stress
hormones including glucocorticoids and catecholamines
(Webster et al., 2002; Glaser and Kiecolt-Glaser, 2005). The
systemic elevation of glucocorticoids can attenuate the normal
inflammatory and cellular immune responses to tissue injury
and infection, and thereby impair wound healing (Hubner
et al., 1996; Padgett et al., 1998). In contrast to the immune
suppressive effects of glucocorticoids, a large body of
evidence supports the opposing action of stress-released
catecholamines in augmenting the acute inflammatory
response, especially when the response is in conjunction
with tissue injury and infection (Bergmann and Sautner,
2002; Flierl et al., 2007). Catecholamines such as
epinephrine can interact with all the cellular components
of the immune system, as lymphocytes, macrophages, and
neutrophils (polymorphonuclear leukocytes (PMNs)) express
a- and b-adrenergic receptors (ARs) (Kohm and Sanders, 2001;
Kavelaars, 2002). Systemic elevation of catecholamine is
emblematic of most physiological stressors, including
trauma, burn injury, and sepsis, as well as chronic psycho-
logical stress (Engelman et al., 1983; Vanitallie, 2002;
Sivamani et al., 2009). Levels of circulating epinephrine can
increase up to 10-fold in patients exposed to high stress during
burn injury (Sedowofia et al., 1998; Jeschke et al., 2011).
These elevated levels of epinephrine can result in enhanced
release of proinflammatory cytokines including tumor necrosis
factor-a, IL-1b, and IL-6 (Frost et al., 2004; Johnson et al.,
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2005; Wong et al., 2012). As these cytokines can recruit
PMNs to the site of inflammation, their generation as a result
of catecholamine stress could provide a link to the observed
increase in PMN trafficking to the lung and liver of mice that
have been challenged with high doses of epinephrine (Morken
et al., 2002; von Montfort et al., 2008). In addition,
extraneuronal generation of epinephrine within the wound
by PMNs themselves provides a potential for amplification of
the catecholamine-mediated inflammatory response (Flierl
et al., 2007). Despite recent advances in understanding the
role of epinephrine on inflammatory response, and emerging
evidence that stress impairs healing, the precise mechanism
by which stress-induced epinephrine has an impact on the
PMN-dependent innate immune response and contributes to
wound chronicity is unclear.
Using an animal model to mimic chronic epinephrine-
dependent stress, we examined how b2AR activation by
epinephrine alters the kinetics of PMN trafficking to the site
of a skin wound and its effect on wound healing. These studies
demonstrate that epinephrine stress promotes sustained PMN
trafficking within the wound site. Further, we provide evi-
dence that IL-6 is the key proinflammatory cytokine that is
critical for this epinephrine-induced PMN wound trafficking
and the resultant impairment of wound healing.
RESULTS
Epinephrine stress mediates persistent PMN trafficking into skin
wounds and delays their healing
Chronic epinephrine stress was emulated by the implanta-
tion of an osmotic pump that provided sustained delivery
of epinephrine (5 mg kg1 per day) or saline (control)
immediately after skin wounding. The continuous delivery
of epinephrine resulted in a 2-fold increase in plasma
epinephrine levels compared with saline control at day 5
after wounding (Figure 1a), which is comparable to the value
measured in a murine model of chronic isolation stress (Itoh
et al., 2006). Mice that were exposed to this sustained levels
of epinephrine exhibited delayed wound healing compared
with control mice (saline-infused) (Figure 1b and c) or with
mice treated with a lower dose of epinephrine (2.5 mg kg 1
per day) (Supplementary Figure S1 online). To investigate
how increased levels of circulating epinephrine influence the
dynamics of PMN infiltration within the wound bed, whole
animal fluorescence imaging of transgenic mice expressing
the lysozyme-EGFP gene (enhanced green fluorescent pro-
tein-lysozyme M (lys) knock-in mice (EGFP-lys-mice)) was
used. This model provides a linear EGFP signal with increased
influx over time, in which 495% of the EGFPhigh cells were
previously confirmed as mature PMNs (Kim et al., 2008). At
day 2 after wounding, the extent of PMN recruitment was
significantly augmented in the wounds of epinephrine-
stressed mice and their increased trafficking to the wound
persisted up to day 8 (Figure 1d). This is in contrast to the
gradual decline in wound PMNs observed in the control mice
(Figure 1d) or in the low-dose epinephrine-stressed mice
(Supplementary Figure S1 online), which paralleled the
normal wound closure trajectory. The increased PMN traf-
ficking to wounds of epinephrine-stressed mice was also
confirmed by flow cytometric analysis of cells harvested from
wounds on day 7. The number of Ly6Gþ CD11bþ PMNs
within the wounds of epinephrine-stressed mice was double
that of control mice (Figure 1e). Taken together, these data
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Figure 1. Effects of epinephrine (Epi) on wound polymorphonuclear leukocyte (PMN) trafficking and wound healing. (a–d) EGFP-lys mice (enhanced green
fluorescent protein-lysozyme M (lys) knock-in mice) and (e) C57BL6 wild-type mice were systemically administered sterile saline or epinephrine (5 mg kg1 per
day). (a) Plasma epinephrine levels were measured on day 5 after wounding. (b) Kinetics of wound closure and representative wound images. (c) Wound re-
epithelialization measured from histological sections collected on day 8 after wounding. Red line indicates a re-epithelialized region. (d) Kinetics of wound EGFP-
PMN fluorescence and representative images. (e) Wound PMN (CD11bþ Ly6Gþ cell) numbers were quantified by flow cytometric analysis of cells harvested
from wounded skin of mice treated with either saline or epinephrine on day 7 after wounding. Representative FACS plot (left panel) and quantification (right panel);
n¼ 6–8 mice in each group. *Po0.05 versus saline group.
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show that the extent and persistence of PMN recruitment is
increased in mice that have elevated levels of plasma
epinephrine, correlating with the observed delay in wound
closure.
The persistence of wound PMN trafficking is responsible for
epinephrine stress–mediated delayed healing
As epinephrine-stressed mice exhibited both a marked increase
in PMN trafficking to the wound and a delay in healing, we set
out to determine whether these two observations were causally
related. For this, mice were systemically depleted of PMNs
with an antineutrophil mAb (Gr-1) that was administered daily,
beginning at day 1 after wounding—the time point that PMN
recruitment increased in response to epinephrine compared
with saline infusion (Figure 2a). When stressed with systemic
elevation of epinephrine, PMN-depleted mice had significantly
attenuated numbers of EGFP-PMNs recruited to the wound on
days 2 through 8 as compared with mice treated with an IgG
isotype control (Figure 2b). In addition, the antibody inhibition
of PMN trafficking into the wound significantly increased the
rate of wound closure for epinephrine-stressed mice (by 57%,
Po0.05 vs. epinephrine only), but the effect was negligible on
saline-treated mice (Figure 2c). These findings support the
notion that persistent PMN trafficking contributes to the im-
paired wound healing observed in epinephrine-stressed mice.
How might epinephrine stress lead to persistence of PMN
numbers within the wound? A recent study has ascribed the
persistent PMN trafficking observed in wounds in restraint-
stressed mice to an increase in wound bacterial burden (Tymen
et al., 2013). This may be a function of the increase in cortisol
levels or experimental conditions that is associated with the
latter model (Campbell et al., 2001; Ridder et al., 2005). In our
current study using epinephrine-stressed mice, a very low
bacterial colony formation was detected with no significant
difference between saline and epinephrine treatment (Supple-
mentary Figure S2 online). As PMN numbers in the peripheral
circulation were comparable between epinephrine- and saline
control-treated animals despite the remarkable difference in
wound PMN trafficking (Supplementary Figure S3 online),
we hypothesized that this persistence might be due to the
2.5E+09
a
b
c d
Saline+IgG Epi+IgG
Saline+Gr-1
Saline+IgG
Saline Epi
##
Saline+Gr-1
Epi+Gr-1
Epi+IgG
*
Epi+Gr-1
2.0E+09
1.5E+09
1.0E+09
#
5.0E+08
0.0E+00
2.5E+09
2.0E+09
1.5E+09
1.0E+09
5.0E+08
0.0E+00
EG
FP
-P
M
N 
flu
or
es
ce
nc
e
(p–
1  
s–
1  
cm
–
2  
sr
–
1 )
W
o
u
n
d 
siz
e
(%
 of
 in
itia
l v
a
lu
e)
0 1 2 3
Days after wounding
* *
* * *
Days after wounding
4 5 6 7 8
0 1 2 3
Days after wounding
Saline or Epi
Skin wounding Anti-Gr-1 mAb or IgG (intraperitoneally)
4 5 6 7 8
0
0
1
1
2
2
3
3
Days after wounding
4
4
5
5
H
al
-li
fe
 o
f E
G
FP
-P
M
N 
(da
ys
)
6 7 8
0 1 2 3 4 5 6 7 8
100.00
120.00
80.00
60.00
40.00
20.00
0.00
Figure 2. The persistence of wound polymorphonuclear leukocyte (PMN) trafficking is responsible for epinephrine (Epi) stress-mediated delayed healing.
(a) Experimental design for delayed depletion of systemic enhanced green fluorescent protein (EGFP)-PMNs. Systemic PMNs were depleted with anti-neutrophil
antibody (Gr-1 mAb) treatment from saline-treated (SalineþGr-1) and epinephrine-treated EGFP-lys mice (5 mg/kg1 per day, EpiþGr-1). Kinetics of (b) wound
EGFP-PMNs and (c) wound closure were determined and results were compared with mice that received isotype control (salineþ IgG or Epiþ IgG); n¼5–6 mice
in each group. #Po0.05 between salineþ IgG versus salineþGr-1 and *Po0.05 between Epiþ IgG versus EpiþGr-1. (d) Calculation of the half-life of PMNs
infiltrating the wound based on the rate of EGFP-fluorescence signal decay (see Materials and Methods and Supplementary Figure S4 online); n¼ 3–4 mice in each
group. ##Po0.05 versus saline control.
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capacity of PMNs infiltrating the wound to evade apoptosis
and extend their survival. This was examined by an in vivo
quantitation of the half-life of EGFP-labeled mature PMNs
adoptively transferred and infiltrating the wound using a
technique that we reported recently (Kim et al., 2011). Non-
proliferative mature EGFP-PMNs, defined as c-kit EGFPhigh
cells (1 107 cells), were isolated by FACS sorting from
bone marrow cells of EGFP-lys-mice and adoptively trans-
ferred by intravenous injection into C57BL/6 mice that were
epinephrine-stressed or saline controls. As the number of
circulating EGFPhigh cells rapidly decrease to undetectable
levels after infusion by day 2 (Supplementary Figure S4a
online), any observed EGFP-PMN fluorescence signal within
the wound after this time point is attributed to prolonged
survival of adoptively transferred PMNs that rapidly infiltrate
the wound. Estimation of the half-life of EGFP-PMNs based on
the rate of fluorescence signal decay (Supplementary Figure
S4b online) revealed that PMNs within wounds of epinephrine-
stressed mice survived 2-fold longer than those in the saline-
treated controls (Figure 2d; 4.23±0.05 days for epinephrine
vs. 1.86±0.21 days for saline control; Po0.01). These data
suggest that epinephrine promoted persistent PMN trafficking
in the wound in part by prolonging the survival of the PMNs
that infiltrated the wound environment.
Epinephrine stress–mediated PMN persistence and impaired
wound healing is b2AR-dependent
The effects of epinephrine are mediated by their binding to
subtypes of ARs, a1, a2, b1, b2, and b3 receptors, and their
downstream signaling after activation (Insel, 1996; Small
et al., 2003). However, recently published data support the
potential role of b2AR in wound healing, both by modulating
the proinflammatory response (Tan et al., 2007; Rough et al.,
2009) and impairing wound re-epithelialization (Sivamani
et al., 2009). Hence, we examined whether epinephrine
stress induced PMN trafficking to wound sites and whether
impaired wound healing was mediated by a b2AR-dependent
mechanism. We therefore evaluated the role of b2AR-
dependent signaling on PMN trafficking and wound size
using a pharmacological agonist (salbutamol) and antagonist
(ICI 118,551) specific for the b2AR (Baker, 2005) in wounded
EGFP-lys mice. Treatment of mice with salbutamol (3 mg kg 1
per day) resulted in a delay in wound healing and prolonged
trafficking of PMN to the wound, equivalent to that induced
by epinephrine stress (Figure 3a and b). On the other hand,
treatment of epinephrine-stressed mice with the antagonist ICI
118,551 (0.7 mg kg 1 per day) remarkably attenuated PMN
trafficking to the wound. This was also confirmed by flow
cytometric analysis of Ly6Gþ CD11bþ PMN number
harvested from wounds on day 7, in which ICI 118,551
treatment significantly reduced Ly6Gþ CD11bþ PMNs
within wounds down to the level of saline control mice
(Supplementary Figure S5 online). Although the kinetics of
wound closure were comparable in the epinephrine- and
salbutamol-treated mice, treatment with the b2AR antagonist
(ICI 118,551) significantly accelerated wound closure in
epinephrine-treated mice on day 8, which is comparable to
that of saline control mice (Figure 3b). These findings suggest
that prolonged exposure to elevated levels of epinephrine
results in persistent PMN presence in the wound site via b2AR
activation, which in turn delays wound repair.
IL-6 is a critical regulator of persistent PMN trafficking in local
wounds of epinephrine-treated mice
We next examined whether the epinephrine stress–mediated
alterations in wound PMN trafficking correlated with altered
expression of proinflammatory cytokines during the late phase
of wound repair. Protein levels of IL-1b, tumor necrosis
factor-a, IL-1a, IL-6, and GM-CSF were measured from tissue
harvested from the wounded skin on day 5 after wounding
using a multiplex cytokine assay. Wound tissue levels of IL-6
were substantially increased by 140% (Figures 4a; Po0.05 vs.
saline) in the epinephrine-treated animals, but protein levels
of other proinflammatory cytokines (IL-1b, tumor necrosis
factor-a, IL-1a, and GM-CSF) were not significantly altered as
compared with saline controls, despite their trend toward an
increase in tissue levels (Supplementary Figure S6 online).
This finding prompted us to investigate whether an
increased tissue level of IL-6 mediated the persistent EGFP-
PMN trafficking seen in the epinephrine-stressed wounds. To
accomplish this, the local activity of IL-6 was blocked by the
subcutaneous injection of an anti-IL-6 antibody (0.1 mg) into
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the wound bed, beginning on day 1 after wounding, and
continued every other day up to day 5 after wounding
(Figure 4b). Indeed, the anti-IL-6 antibody treatment signifi-
cantly attenuated wound EGFP-PMN trafficking by 40% on
day 8 after wounding in epinephrine-stressed mice (Epi-anti-
IL-6) compared with animals treated with the isotype control
(Epi-IgG) (Figure 4c). Furthermore, the rate of wound closure in
the epinephrine-stressed and anti-IL-6-treated mice was accele-
rated 2-fold compared with mice that received isotype control
(Figure 4d). Taken together, these data indicate that epinephr-
ine upregulates IL-6 levels at the site of local skin wounding
and this provides a critical signal to promote PMN persistence
in the wound that results in delayed wound healing.
Epinephrine stress mediates increased IL-6 expression in
macrophages via b2AR-dependent mechanism
Macrophages within inflammatory wounds have an important
role in generating a number of proinflammatory cytokines,
including IL-6 (Stow et al., 2009). Given the crucial role of IL-
6 in mediating epinephrine stress in PMN wound trafficking,
along with the observation that blockade of b2AR activation
can reduce epinephrine-mediated PMN trafficking, we
examined whether epinephrine can stimulate enhanced IL-6
from naive macrophages via b2AR activation. Treatment of
macrophages with epinephrine (1mM) resulted in an B3-fold
increase in IL-6 production compared with untreated control
(Figure 5a). The epinephrine-induced production of IL-6 was
blocked by the antagonist ICI 118,551 (1mM). We next sought
in vivo evidence of whether wound macrophages were
responsible for b2AR-dependent IL-6 production in response
to epinephrine. For this, F4/80þ macrophages were harvested
from day 8 skin wounds in epinephrine-stressed mice
(5 mg kg1 per day) or from epinephrine-stressed mice treated
with ICI 118,551 (0.7 mg kg1 per day), and IL-6 gene
expression was then determined using real-time quantitative
PCR analysis. Consistent with in vitro data of IL-6 ELISA
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(Figure 5a), treatment of the epinephrine-stressed animals with
ICI 118,551 (Epiþ ICI) significantly attenuated IL-6 gene
expression of F4/80þ macrophages by B50% (Po0.05)
(Figure 5b). These data support a crucial role for wound-
resident macrophages in producing IL-6 via b2AR activation in
response to systemic elevations of epinephrine.
We next sought to determine whether sustained elevation of
systemic levels of epinephrine alters the inflammatory pheno-
type of wound macrophages. We examined the surface
expression of Ly6C in F4/80þ wound macrophages, as
previous studies have reported that F4/80þ Ly6Chigh macro-
phages exhibit a proinflammatory phenotype and cytotoxic
activities, whereas F4/80þ Ly6Clow macrophages exhibit an
anti-inflammatory phenotype and enhanced tissue repair
activities (Arnold et al., 2007; Nahrendorf et al., 2007). The
total number of F4/80þ macrophages was not different
between Epi and Epiþ ICI mice (Supplementary Figure S7
online). However, the number of proinflammatory F4/80þ
Ly6Chigh cells was significantly decreased by B40% in the
b2AR antagonist-treated animals (Epiþ ICI; Figure 5c). These
data suggest that the epinephrine stress–mediated activation of
b2AR signaling contributes to the increased trafficking or local
differentiation of the proinflammatory macrophages within
wounds, which then results in persistent inflammation and
delayed wound healing.
DISCUSSION
Using a pharmacologic stress paradigm, we demonstrate that
prolonged systemic exposure to epinephrine results in persis-
tent PMN trafficking and prolonged survival within the wound
site via b2AR-dependent and IL-6-mediated mechanisms and
this in turn impairs wound repair. This study expands our
current understanding of stress-mediated impairment of
wound healing and provides pivotal insight into the mechan-
ism by which epinephrine stress exacerbates inflammation
and impairs wound healing.
There is significant clinical evidence linking chronic stress
to the exacerbation of many disease processes in the immu-
nologic, neoplastic, and cardiovascular realms (Wong et al.,
2012; Hassan et al., 2013). Recent work has expanded this
link to wound healing, wherein chronic stress is associated
with delayed healing in both experimental and clinical
scenarios (Kiecolt-Glaser et al., 1995; Walburn et al., 2009).
Here, we focused on the catecholamine epinephrine, whose
elevation parallels both acute and chronic stress, and explored
hypothesis that stress-induced epinephrine contributes to
impairment of healing via immunomodulation of the wound
environment. In support of this, we demonstrated that
systemically elevated epinephrine superimposed upon skin
injury resulted in impaired wound healing by prolongation of
wound inflammation, which led to persistent PMN traffi-
cking. Epinephrine stress may impair healing by multiple,
overlapping mechanisms. Our recent study demonstrating the
direct role of epinephrine in inhibiting keratinocyte motility
and re-epithelialization is one way by which epinephrine
stress impairs healing (Sivamani et al., 2009). This study
unveils another mechanism by which epinephrine contri-
butes to impairment of wound healing by promoting a
PMN-dependent inflammatory response.
Previous studies have demonstrated systemic increases in
plasma IL-6 levels in response to diverse stressors including
long-term caregiving (Kiecolt-Glaser et al., 2003), burn injury
(Kawakami et al., 2001), psychological stress (Takaki et al.,
1994), and childhood maltreatment stress (Carpenter et al.,
2010). Here we demonstrate a stress-mediated increase in IL-6
localized to the wound niche. Our findings that the local
blockade of IL-6 activity with anti-IL-6 antibody could
attenuate wound PMN trafficking and improve wound
healing strongly supports the notion that IL-6 is a critical
signal linking epinephrine effects with persistent PMN traffi-
cking. IL-6 can promote tissue PMN trafficking during the
inflammatory response by selective regulation of inflammatory
chemokines or mediating anti-apoptotic events. Multiple lines
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Figure 5. Epinephrine (Epi) mediates increased IL-6 expression in wound
macrophages via adrenergic receptor (b2AR)-dependent mechanism.
(a) Macrophage production of IL-6 in response to epinephrine (1mM) or
epinephrine with ICI 118,551 (ICI) (1mM). IL-6 production was quantified by
ELISA assay. (b) Gene expressions of IL-6 in macrophages isolated from
wounds of mice treated with either epinephrine or epinephrine with ICI
118,551 at day 8 after wounding. b2-Microglobulin was used for reference
gene. (c) The effect of b2AR antagonist on epinephrine-mediated F4/80þ
Ly6Ghi cells trafficking in wounds. Cells were harvested from wounds of mice
treated with epinephrine (5 mg kg 1 per day) or epinephrine with ICI 118,551
(0.7mg kg 1 per day) at day 8 and were analyzed using flow cytometry; n¼4–
5 mice in each group. *Po0.05 between Epi versus Epiþ ICI and #Po0.05
between Epi versus saline.
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of evidence support a relationship between increased IL-6
level and prolonged lifetime of PMNs (Daffern et al., 1999;
Ottonello et al., 2002; Asensi et al., 2004), which is consistent
with our observation of extended survival of PMNs in wounds
under epinephrine stress.
Another important finding from this study was that epi-
nephrine-mediated b2AR activation primed wound-associated
macrophages into a proinflammatory profile, and this, in turn,
was responsible for amplified IL-6 production and persistent
PMN trafficking. This conclusion is supported by experi-
ments using a b2AR-specific pharmacological antagonist
to inhibit epinephrine-mediated responses. We found that
blockade of b2AR signaling significantly (1) attenuates
epinephrine-mediated trafficking of the proinflammatory
phenotype of macrophages (F4/80þ Ly6Chigh macrophages),
(2) attenuates epinephrine-induced IL-6 gene expression from
wound-isolated macrophages, and (3) attenuates epinephrine-
mediated wound PMN trafficking. Macrophages demonstrate
considerable plasticity in adjusting their phenotype in
response to environmental cues (Mosser and Edwards,
2008). Interestingly, repeated psychosocial stress can
increase the number of Ly6Chigh macrophages that traffic to
inflamed tissue in the brain, and chronic restraint stress
similarly increases the trafficking of this proinflammatory
macrophage phenotype to breast cancer tumors, with both
of these responses blocked by a bAR antagonist (Wohleb
et al., 2011). In addition, the role of b2AR signaling in
modulating immunological responses has been supported by
the demonstration that its activation enhances proinfla-
mmatory cytokines and, conversely, by the efficacy of b2AR
blockade in attenuating the inflammatory responses in various
pathological conditions including traumatic injury, burn
injury, and sepsis (Rough et al., 2009). Our findings are
consistent with previous demonstrations of induction of a
proinflammatory profile of macrophages by b2AR activation,
and extend those findings by revealing a stress/epinephrine-
mediated activation of the b2AR signaling pathway that can
alter IL-6 cytokine expression in macrophages in the wound,
which drives persistent PMN trafficking. In addition, it is
conceivable that macrophages might be pivotal regulators in
the epinephrine-mediated proinflammatory response, not only
for PMN trafficking but also for other significant aspects of
wound repair, given the observation that the inhibition of PMN
infiltration with either anti-Gr1 or anti-IL-6 antibody treatment
resulted in partial recovery of optimal wound healing, whereas
the blockade of b2AR signaling fully recovered wound closure
in the epinephrine-treated mice (Figure 3b).
In summary, this study reveals a role of epinephrine in
promoting persistent inflammation in skin wounds and
demonstrates the pivotal mechanistic role played by b2AR-
dependent IL-6 production in the persistent PMN trafficking to
the wound (Supplementary Figure S8 online). As sustained
elevation of systemic epinephrine has been associated with
different stress etiologies, such as trauma, burn injury, and
sepsis (Engelman et al., 1983; Vanitallie, 2002; Sivamani
et al., 2009), targeting the b2AR-dependent signaling
pathway in these stressed patients may provide a clinically
effective immunomodulatory therapeutic strategy to normalize
macrophage phenotype, optimize the number of PMNs,
and thereby avoid prolonged inflammation in cutaneous
wounds.
MATERIALS AND METHODS
Mice
Female EGFP-lys mice backcrossed onto C57BL/6 at least eight
generations (Faust et al., 2000) (kind gift from Dr Thomas Graf) and
C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME) were used in the
experiments. All animal experiments were approved by the University
of California at Davis Institutional Animal Care and Use Committee
(IACUC) and were performed following the guidelines of the
Animal Welfare Act and the Health Research Extension Act. Further
details are provided in the Supplementary Materials and Methods
online.
Mouse model of skin wounding and osmotic pump implantation
Mouse skin wounding and osmotic pump implantation were per-
formed as described previously (Kim et al., 2008; Sivamani et al.,
2009; Kim et al., 2011). Briefly, a circular full-thickness wound (6 mm
in diameter) was made on the back skin of the mouse using a skin
biopsy punch (Robbins Instruments, Chatham, NJ). Immediately after
skin wounding, while the mouse was still anesthetized, an osmotic
minipump (1002 model; Alzet; Durect, Cupertino, CA) was implanted
subcutaneously in the side flank. Further details are provided in the
Supplementary Materials and Methods online.
Noninvasive quantification of wound EGFP-PMN trafficking
The trafficking of EGFP-PMNs at wound sites over time was
determined noninvasively using the IVIS 100 imaging system (Caliper
Life Sciences, Hopkinton, MA) as described previously (Kim et al.,
2008) and in the Supplementary Materials and Methods online.
Flow cytometric immunophenotyping of wound PMNs and
macrophages
At selected time points after wounding, skin wounds were harvested
from C57BL/6 mice treated with saline, epinephrine (5 mg kg 1 per
day), or epinephrine with b2AR antagonist ICI 118,551 (0.7 mg kg
 1
per day) and the immunophenotyping of wound PMNs and macro-
phages was performed as described in the Supplementary Materials
and Methods online.
Immunodepletion of systemic PMNs
Systemic PMNs were depleted by multiple injections (intraperitone-
ally) of anti-Gr-1 mAb (0.1 mg each injection, RB6-8C5 clone;
eBioscience, San Diego, CA) or isotype control IgG (eBioscience)
every other day, starting from day 1 after wounding up to day 5.
Plasma epinephrine measurement
Plasma epinephrine measurements were recorded using an enzyme
immunoassay kit (Epinephrine ELISA kit; Rocky Mountain Diagnostics,
Colorado Springs, CO) as described in the Supplementary Materials
and Methods online.
The quantification of PMN half-life in the wound
The quantification of PMN half-life in the wound was performed as
described previously (Kim et al., 2011) and in the Supplementary
Materials and Methods online.
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Multiplex cytokine assay from wounded skin
The proinflammatory cytokine levels in the wounded skin were
measured using MILLIPLEX MAP 13-plex Cytokine Kit (Millipore,
Billerica, MA) as described in the Supplementary Materials and
Methods online.
Anti-IL-6 antibody treatment of murine wounds
Monoclonal mouse anti-IL-6 antibody (clone MP520F3; R&D System,
Minneapolis, MN) or isotype control, IgG1 (R&D system). was subcu-
taneously injected into the periphery of the wound bed (0.1 mg each
injection) every other day, starting 24 hours after wounding up to day 5.
IL-6 ELISA assay from mouse macrophage
IL-6 ELISA from mouse macrophages was performed as described in
the Supplementary Material and Methods online.
Real-time quantitative PCR for IL-6 gene expression from wound
macrophages
Real-time quantitative PCR analysis for the IL-6 gene was performed
using macrophages isolated from wounds of EGFP-lys mice treated
with either epinephrine (5 mg kg 1 per day) or epinephrine with
b2AR antagonist ICI 118,551 (0.7 mg kg
 1 per day) at day 8 after
wounding; the detailed experimental procedure is described in the
Supplementary Materials and Methods online.
Statistical analysis
Data analysis was performed using GraphPad Prism version 5.0
software (GraphPad Software, San Diego, CA). Statistical significance
between two groups was determined by two-tailed unpaired t-tests.
Statistical significance among multiple groups was analyzed using
one-way analysis of variance followed by Tukey’s post-test for
secondary analysis for significance. P-values o0.05 were considered
statistically significant. Data are expressed as mean±SEM.
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